Registry of Lobbyists
Total Number of Communication Reports: 100
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Intellectual Property
|
International Trade regarding intellectual property provisions in bilateral and multilateral trade agreements.
|
Policies or Program
|
PHARMACEUTICAL COMPANY Manufacturing and commercialization of generic and over-the-counter products, as well as marketing of biosimilars and specialty medicines.
Fabien Paquette, General Manager
Address:
30 Novopharm Court
Toronto, ON M1B 2K9
Canada
Telephone number:
514-705-4649
Teva Canada Limited / Teva Canada Limitee does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Please note that registrations and registration updates with effective dates of January 19, 2026, or after will be subject to the new significant part of duties threshold. For more information, please consult our interpretation bulletin.